Media thread, page-448

Extract from the article below dated Jan 3rd 2024


Why do Australian medical inventions get commercialised overseas?

..."For Orthocell CEO Paul Anderson, the situation is not quite so bleak. Orthocell, a regenerative medicine company, has recently launched its bone regeneration product into the US and has announced plans to also expand its nerve product there.

Anderson’s strategy is a little different: while Orthocell will maintain a manufacturing base in Australia, he’s spent years forging partnerships and connections in the US to gain a foothold in the world’s biggest pharmaceutical market.

Australia is increasingly seen as doing two things well: innovation and manufacturing.

Paul Anderson​

“Our plan is to commercialise overseas but manufacture in Australia,” he says. “From a global attractiveness perspective, Australia is increasingly seen as doing two things well: innovation and manufacturing,” he says.

With new markets emerging in India and China, Australia is well-placed within the Indo-Pacific to capitalise on this, Anderson says. “Both those countries have had issues in driving product development to its end phase, because of COVID19, geo-political issues or IP issues.”

Orthocell has two products already approved by Australia, European and American regulators. Anderson believes there’s no reason an Australian company cannot develop drugs and medical devices locally and export overseas.

“The US is the world’s biggest market – you just have to be there in some way, shape or form,” he adds."

https://cosmosmagazine.com/my-cosmo...dical-inventions-get-commercialised-overseas/